Searchable abstracts of presentations at key conferences in endocrinology

ea0019p82 | Clinical practice/governance and case reports | SFEBES2009

Flucloxacillin induced hypokalaemia and hypomagnesaemia

Bdiri A , Smith M , Lawrence J

A 70-year-old woman presented with low back pain. A diagnosis of discitis (L4-L5) was made and the patient was started on IV flucloxacillin 1 g every 6 h and fusidic acid. The back pain was improving and the serum electrolytes were all within normal range with potassium level at 4.4 mmol/l (normal: 4.0–5.5) and magnesium at 0.68 mmol/l (normal: 0.7–1.1). However two weeks after starting the IV flucloxacillin, the patient’s electrolytes showed a persistent hypoka...

ea0025p33 | Clinical biochemistry | SFEBES2011

Cross reactivity of Spironolactone with androstenedione immunoassay

Katreddy Venkata , Bdiri Ashraf , Ashawesh Khaled

Introduction: Hirsutism, the presence of terminal (coarse) hairs that appear in a male-like pattern, affects 5–10% of women and may cause concern for an underlying endocrine disorder or malignancy. Spironolactone compete for the androgen receptor in the hair follicle, therefore, it is frequently used in treatment of hirsutism. We report a case, in which treatment of hirsutism with Spironolactone interfered with androstenedione immunoassay and raised unnecessary concern ab...

ea0015p78 | Clinical practice/governance and case reports | SFEBES2008

Zoledronate associated severe hypocalcaemia causing bradyarrhythmia that required urgent cardiac pacing

Bdiri Ashref , Lawrence James , Jones A , Smith Martin

A 71-year-old man with carcinoma of prostate and bony metastasis, presented with acute bradyarrhythmia, severe hypocalcaemia and acute renal failure 72 h after intravenous infusion of zoledronate. Before therapy, serum calcium was 2.14 mmol/l (normal, 2.10–2.55 mmol/l), serum phosphate 1.4 mmol/l (normal, 0.8–1.5 mmol/l), serum creatinine 95 umol/l and eGFR 74 ml/min. 25OH vitamin D was not measured. Three days later he presented with a syncopal episode. Initial bloo...

ea0015p87 | Clinical practice/governance and case reports | SFEBES2008

Sarcoidosis associated hypercalcaemia and renal failure mimicking lymphoma

Bdiri Ashref , Smith Martin , Lawrence James

We describe two cases of sarcoidosis associated hypercalcaemia, renal failure and anaemia mimicking lymphoma. The diagnosis was made by lymph node biopsy. Within weeks of starting oral steroids, symptoms resolved and biochemical abnormalities almost normalized.Case 1: A 66-year-old lady, presented with generalized weakness, lymphadenopathy and splenomegaly. Hb 96 g/l, MCV 91, urea 16.6 mmol/l, creatinine 227 umol/l, eGFR 15 ml/min, serum calcium 3.4 mmol...

ea0025p329 | Thyroid | SFEBES2011

Hypothyroidism and adrenaleukodystrophy, a rare association

Katreddy Venkata , Bdiri Ashraf , Al-Akbar Azizul Aziz , Ashawesh Khaled

Introduction: Adrenaleukodystrophy is an X linked disorder associated with functional defect of very long fatty acid (VLFCA) oxidation leading to accumulation of VLFCA in the white matter of brain and adrenal cortex. It usually presents with adrenal insufficiency and neurological problems and has association with other autoimmune conditions reported so far including vitiligo, ulcerative colitis. We report a case of adrenaleukodystrophy, vitiligo and hypothyroidism.<p class...

ea0013p334 | Thyroid | SFEBES2007

Severe thyroid orbitopathy and ocular myasthenia gravis. A challenging case, and review of the literature

Bdiri Ashref , Heard Wendy , Hillier Charles , Parkin Ben , Taylor Martin

We describe an 80 year-old man with Graves’ thyrotoxicosis and thyroid orbitoapthy accompanied by ocular myasthenia gravis.He presented in 2004 with chemosis, exophthalmos, diplopia, ptosis, and restricted movements. He also gave history of weight loss (six kilograms). FT4 29, FT3 7.7 and TSH 0.04. MRI Orbits revealed swelling of the extra-ocular muscles.Ocular movement was markedly restricted but a curious feature of the pres...

ea0025p20 | Bone | SFEBES2011

Localisation studies in primary hyperparathyroidism: our experience

Katreddy Venkata , Al-akbar A N B Abduk Aziz , Bdiri Ashraf , Ball Andrew , Ashawesh Khaled

Introduction: Primary hyperparathyroidism is not an uncommon disease with incidence of ~25–30 cases per 100 000 people, whether caused by adenoma or hyperplasia, can be cured surgically with a high rate of success. Over past decade minimally invasive surgery has become mainstay of treatment compared to traditional bilateral exploration approach. Accurate preoperative localisation of parathyroid disease is absolutely imperative for effective minimally invasive surgery....